MR
Melissa Rhodes sold $371K of AVLN stock
Melissa Rhodes, Chief Operating Officer of Avalyn Pharma Inc. (AVLN), sold 13,300 shares of AVLN stock worth $371K, per an SEC Form 4 filed Nov 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 17, 2026, 2 days before it was made public.
AVLN has moved +2.8% since the trade date, from $27.92 to $28.70 (Nov 19, 2026 close).
- Traded
- Nov 17, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 2 days
- Price since
- +2.8%
- Role
- Chief Operating Officer
- Source
- SEC Form 4